ClinicalTrials.govpublic full text
Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy
colorectal neoplasms, metastases, neoplasm, egfr-undetectable, metastatic colorectal cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 811779
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.